MDSquare
MDSquare, operating as AHPO since March 2025, is a Seoul-based telemedicine company providing a mobile platform for remote doctor consultations, digital prescriptions, and pharmacy connectivity, serving both individual consumers and enterprise clients.
- Company typePrivate
- Founded2016
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What MDSquare does
MDSquare (엠디스퀘어), now operating under the AHPO (아포) brand since its March 2025 rebrand, is a Seoul-headquartered private telemedicine company founded in May 2016. The company built and operates a mobile telemedicine platform that connects individual patients with verified medical professionals for remote consultations, issues digital prescriptions that can be transmitted directly to pharmacies of the patient's choice, and provides hospital/pharmacy search and matching along with family-level health record management under a single account. Core products include the unified AHPO platform alongside the legacy MD Talk (엠디톡) mobile consultation service and MD Care (엠디케어) telehealth service used for B2B deployments.
The underlying technology is a mobile-first telemedicine platform with separate provider portals for hospitals (doctor.ahpo.io) and pharmacies (pharmacy.ahpo.io), enabling end-to-end digital workflow from consultation through prescription fulfillment. The platform notably includes a regulatory sandbox license granted in May 2021 for delivering telemedicine services to overseas Korean nationals—a permission that materially differentiates MDSquare from purely domestic telemedicine operators. The company claims to have launched Korea's first telemedicine service in March 2020 and reports approximately 400,000+ app downloads and 100,000+ platform users with a 4.3/5 satisfaction score.
MDSquare employs a dual B2C/B2B model. Consumers download the app for free and access consultations on a pay-as-you-go basis, while hospitals and pharmacies are onboarded at zero entry cost with no monthly usage fees (freemium model). Revenue is generated primarily through platform commissions/transaction fees from healthcare providers and through subscription-based B2B enterprise health programs sold to corporate clients such as Sanofi (since September 2022) and Samsung Materials (since May 2022), with academic deployments including a co-developed app with Yonsei University (June 2023). The company has raised approximately $3.7M cumulatively across a Pre-Series A round in July 2022 (2.5 billion KRW from Shinhan Capital, UTC Investment, and BluePoint Partners) and a Blue M Tech investment in November 2024.
MDSquare firmographics
Firmographics- Name
- MDSquare
- Legal name
- MDSQUARE
- Website
- https://mdsqr.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MDSquare, operating as AHPO since March 2025, is a Seoul-based telemedicine company providing a mobile platform for remote doctor consultations, digital prescriptions, and pharmacy connectivity, serving both individual consumers and enterprise clients.
- Ownership category
- akta.pro rank
MDSquare industry classification
Industry- Product category
- Telemedicine Platform
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industries
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG), Medication Adherence, Reminders & Patient Support (HLACAKAF), Pharmacy-Integrated Virtual Care & ePrescribing (Employer Benefit) (HLALADAH)
Keywords
Where MDSquare is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
MDSquare business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform Commission / Transaction Fee: The platform facilitates telemedicine consultations between doctors and patients, with hospitals/pharmacies onboarded to the AHPO platform. Revenue is likely generated through transaction fees or platform commissions from healthcare providers.
- B2B Enterprise Health Programs: MDSquare provides corporate health management programs to enterprise clients such as Sanofi and Samsung物産, generating revenue through corporate service agreements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Hospital/Pharmacy Onboarding — Zero entry cost |
| Freemium | Pay-as-you-go | Consumer Users — Free App Access |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
MDSquare product offering
Product offeringCore offering
MDSquare operates a telemedicine platform that connects patients with hospitals and pharmacies for mobile health consultations and digital prescriptions. The company provides the AHPO consumer app for individuals and MDcare/MDtalk-based enterprise health programs for corporate clients such as Sanofi, Samsung Materials, and Yonsei University. Its services span rapid phone consultations, family health management, hospital/pharmacy search, and digital prescription delivery.
Product overview
MDSquare operates as a digital healthcare platform company offering a unified ecosystem of telehealth services. The core product is AHPO, which integrates MD Talk (for phone-based medical consultations) and MD Care (for telehealth appointments) into a single user experience. The platform connects patients with verified medical professionals for remote consultations, issues digital prescriptions that can be transmitted directly to pharmacies, and provides hospital search and booking functionality. Family health management features allow multiple family members' health records to be managed within one account. The company also provides separate portals for hospitals and pharmacies to manage consultations and prescriptions.
Differentiator
Problem solved
Functional benefit
Brands
- AHPO (아포): Telemedicine platform providing remote medical consultations with doctors, digital prescriptions, and hospital/pharmacy connections
Products and services
- AHPO (formerly MDSquare)
- MDcare (엠디케어)
- MDtalk (엠디톡)
Quantifiable outcome
- 100,000+ active users on the AHPO platform
- +3 more outcomes
Companies that use MDSquare
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
MDSquare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MDSquare partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- 연세대학교 (Yonsei University)coreMDSquare collaborated with Yonsei University in June 2023 to develop a custom digital healthcare service mobile application for the university community.
- SanoficoreSanofi adopted MDSquare's MDcare platform for its employee health management program starting September 2022, providing corporate employees access to telemedicine services.
- 삼성물산 (Samsung Materials)coreSamsung Materials adopted MDcare for its residential employee health management program starting May 2022, enabling employees to access telemedicine consultations.
- NIPA / 엠디톡 월드 (Vietnam Market Entry)minorMDSquare participated in the NIPA DNA non-face-to-face medical treatment Vietnam market entry project in May 2022, collaborating with MDtok World for overseas expansion.
- 한국스마트헬스케어협회 (Korea Smart Healthcare Association)minorPartner organization listed on the MDSquare website as part of the company's trusted partner ecosystem supporting digital healthcare services.
- 대한상공회의소 (Korea Chamber of Commerce and Industry)minorListed as a partner organization supporting MDSquare's ecosystem of trusted partners for digital healthcare services.
- 중소벤처기업부 (Ministry of SMEs and Startups)coreRecognized and supported by the Ministry as the #1 healthcare startup in the Dae-STAR Problem Solver program, providing official backing and visibility for the company's healthcare innovation initiatives.
- KB금융그룹 (KB Financial Group)minorSelected as an innovative startup in KB Financial Group's KB Starters program, providing access to KB's startup ecosystem resources and potential financial services.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
MDSquare competitors and assessment
Company assessmentBroad incumbents
- Amwell: US-based telehealth platform providing virtual consultations, prescription services, and hospital/health system partnerships. Comparable in ambulatory care delivery, hospital integration, and digital prescription workflows.
- Kakao Healthcare: Healthcare arm of Korean internet giant Kakao, offering digital health and telehealth capabilities as part of a broader portfolio. Comparable in that it competes for the same Korean consumer telemedicine demand, though with substantially greater resources.
- Teladoc Health: Global leader in virtual care offering telemedicine, chronic condition management, and integrated health services. Comparable in DTC virtual care model and B2B enterprise health contracts (e.g., employer-sponsored benefits).
- Lunit: Korean AI-driven digital health company with adjacent telehealth/medical-AI offerings. Comparable as a domestic Korea-based digital health platform, though focused more on imaging AI than telemedicine consultations.
Regional players
- Ping An Good Doctor: China-based leading telemedicine and digital health platform offering consultations, prescriptions, and family health management. Comparable in mobile-first integrated healthcare workflow and family-account model, though serving a different geography.
Emerging players
- Babylon Health: Global DTC telemedicine and AI-driven symptom-checking platform. Comparable in app-based virtual consultations and digital prescriptions as a category benchmark for DTC telehealth business models.
- Doctor Avatar (닥터아바타): Korean telemedicine/virtual care startup providing remote consultation services. Comparable as a domestic DTC telehealth competitor, though typically narrower in scope than MDSquare's integrated platform.
Direct peers
- Goodoc (굿닥): Korean mobile medical consultation platform providing chat- and video-based doctor consultations and digital prescriptions to consumers. Directly comparable on DTC telemedicine, prescription delivery, and Korean consumer target market.
- Dr. Now (닥터나우): One of Korea's leading direct-to-consumer telemedicine apps offering phone-based consultations, digital prescriptions, and pharmacy connections. Closely comparable to MDSquare's AHPO platform in target customer, business model, and core consultation workflow.
- TADA Doctor (타닥터): Korean DTC telemedicine service focused on rapid remote consultations and prescription issuance. Comparable in use case (specialist phone consultations, digital prescriptions) and target consumer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
MDSquare social profiles
Digital presenceMDSquare financial estimates
Financial estimateRevenue estimate
Valuation estimate
MDSquare leadership team
Management profileNumber of profiles
Profiles1 record
MDSquare funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MDSquare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MDSquare
What does MDSquare do?
MDSquare operates a telemedicine platform that connects patients with hospitals and pharmacies for mobile health consultations and digital prescriptions. The company provides the AHPO consumer app for individuals and MDcare/MDtalk-based enterprise health programs for corporate clients such as Sanofi, Samsung Materials, and Yonsei University. Its services span rapid phone consultations, family health management, hospital/pharmacy search, and digital prescription delivery.
Is MDSquare a public or private company?
MDSquare is a private company. It is classified as venture growth investor backed and is currently operating.
When was MDSquare founded?
MDSquare was founded in 2016. It employs 11 to 50 people.
Where is MDSquare based?
MDSquare is headquartered in Seoul, South Korea, in the Asia region.
How does MDSquare make money?
Two revenue lines are on record. Platform Commission / Transaction Fee is the primary driver. The others are B2B Enterprise Health Programs.
Who are MDSquare's main competitors?
Broad incumbents on record are Amwell, Kakao Healthcare, Teladoc Health and Lunit. Ping An Good Doctor is listed as a regional player. Emerging players are Babylon Health and Doctor Avatar (닥터아바타). Direct peers are Goodoc (굿닥), Dr. Now (닥터나우) and TADA Doctor (타닥터).
Does MDSquare have an API?
No public API is recorded for MDSquare.
What industry is MDSquare in?
MDSquare's product category is Telemedicine Platform. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM). Its NAICS code is 6211 and its SIC code is 8000.